Association of adipocyte enhancer-binding protein 1 with Alzheimer's disease pathology in human hippocampi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Adipocyte enhancer binding protein 1 (AEBP1) activates inflammatory responses via the NF-κB pathway in macrophages and regulates adipogenesis in preadipocytes. Up-regulation of AEBP1 in the hippocampi of patients with Alzheimer's disease (AD) has been revealed by microarray analyses of autopsied brains from the Japanese general population (the Hisayama study). In this study, we compared the expression patterns of AEBP1 in normal and AD brains, including in the hippocampus, using immunohistochemistry. The subjects were 24 AD cases and 52 non-AD cases. Brain specimens were immunostained with antibodies against AEBP1, tau protein, amyloid β protein, NF-κB, GFAP and Iba-1. In normal brains, AEBP1 immunoreactivity mainly localized to the perikarya of hippocampal pyramidal neurons, and its expression was elevated in the pyramidal neurons and some astrocytes in AD hippocampi. Although AEBP1 immunoreactivity was almost absent in neurons containing neurofibrillary tangles, AEBP1 was highly expressed in neurons with pretangles and in the tau-immunopositive, dystrophic neurites of senile plaques. Nuclear localization of NF-κB was also observed in certain AEBP1-positive neurons in AD cases. Comparison of AD and non-AD cases suggested a positive correlation between the expression level of AEBP1 and the degree of amyloid β pathology. These findings imply that AEBP1 protein has a role in the progression of AD pathology.

Original languageEnglish
Pages (from-to)58-71
Number of pages14
JournalBrain Pathology
Volume28
Issue number1
DOIs
Publication statusPublished - Jan 2018

Fingerprint

Adipocytes
Hippocampus
Carrier Proteins
Pathology
Alzheimer Disease
Pyramidal Cells
Brain
Neurons
Alzheimer disease type 1
Amyloidogenic Proteins
tau Proteins
Adipogenesis
Neurofibrillary Tangles
Amyloid Plaques
Neurites
Microarray Analysis
Amyloid
Astrocytes
Up-Regulation
Immunohistochemistry

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Neuroscience(all)
  • Clinical Neurology

Cite this

@article{07498764ec1344d5a801572c186640ae,
title = "Association of adipocyte enhancer-binding protein 1 with Alzheimer's disease pathology in human hippocampi",
abstract = "Adipocyte enhancer binding protein 1 (AEBP1) activates inflammatory responses via the NF-κB pathway in macrophages and regulates adipogenesis in preadipocytes. Up-regulation of AEBP1 in the hippocampi of patients with Alzheimer's disease (AD) has been revealed by microarray analyses of autopsied brains from the Japanese general population (the Hisayama study). In this study, we compared the expression patterns of AEBP1 in normal and AD brains, including in the hippocampus, using immunohistochemistry. The subjects were 24 AD cases and 52 non-AD cases. Brain specimens were immunostained with antibodies against AEBP1, tau protein, amyloid β protein, NF-κB, GFAP and Iba-1. In normal brains, AEBP1 immunoreactivity mainly localized to the perikarya of hippocampal pyramidal neurons, and its expression was elevated in the pyramidal neurons and some astrocytes in AD hippocampi. Although AEBP1 immunoreactivity was almost absent in neurons containing neurofibrillary tangles, AEBP1 was highly expressed in neurons with pretangles and in the tau-immunopositive, dystrophic neurites of senile plaques. Nuclear localization of NF-κB was also observed in certain AEBP1-positive neurons in AD cases. Comparison of AD and non-AD cases suggested a positive correlation between the expression level of AEBP1 and the degree of amyloid β pathology. These findings imply that AEBP1 protein has a role in the progression of AD pathology.",
author = "Masahiro Shijo and Hiroyuki Honda and Suzuki, {Satoshi O.} and Hideomi Hamasaki and Masaaki Hokama and Nona Abolhassani and Yusaku Nakabeppu and Toshiharu Ninomiya and Takanari Kitazono and Toru Iwaki",
year = "2018",
month = "1",
doi = "10.1111/bpa.12475",
language = "English",
volume = "28",
pages = "58--71",
journal = "Brain Pathology",
issn = "1015-6305",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Association of adipocyte enhancer-binding protein 1 with Alzheimer's disease pathology in human hippocampi

AU - Shijo, Masahiro

AU - Honda, Hiroyuki

AU - Suzuki, Satoshi O.

AU - Hamasaki, Hideomi

AU - Hokama, Masaaki

AU - Abolhassani, Nona

AU - Nakabeppu, Yusaku

AU - Ninomiya, Toshiharu

AU - Kitazono, Takanari

AU - Iwaki, Toru

PY - 2018/1

Y1 - 2018/1

N2 - Adipocyte enhancer binding protein 1 (AEBP1) activates inflammatory responses via the NF-κB pathway in macrophages and regulates adipogenesis in preadipocytes. Up-regulation of AEBP1 in the hippocampi of patients with Alzheimer's disease (AD) has been revealed by microarray analyses of autopsied brains from the Japanese general population (the Hisayama study). In this study, we compared the expression patterns of AEBP1 in normal and AD brains, including in the hippocampus, using immunohistochemistry. The subjects were 24 AD cases and 52 non-AD cases. Brain specimens were immunostained with antibodies against AEBP1, tau protein, amyloid β protein, NF-κB, GFAP and Iba-1. In normal brains, AEBP1 immunoreactivity mainly localized to the perikarya of hippocampal pyramidal neurons, and its expression was elevated in the pyramidal neurons and some astrocytes in AD hippocampi. Although AEBP1 immunoreactivity was almost absent in neurons containing neurofibrillary tangles, AEBP1 was highly expressed in neurons with pretangles and in the tau-immunopositive, dystrophic neurites of senile plaques. Nuclear localization of NF-κB was also observed in certain AEBP1-positive neurons in AD cases. Comparison of AD and non-AD cases suggested a positive correlation between the expression level of AEBP1 and the degree of amyloid β pathology. These findings imply that AEBP1 protein has a role in the progression of AD pathology.

AB - Adipocyte enhancer binding protein 1 (AEBP1) activates inflammatory responses via the NF-κB pathway in macrophages and regulates adipogenesis in preadipocytes. Up-regulation of AEBP1 in the hippocampi of patients with Alzheimer's disease (AD) has been revealed by microarray analyses of autopsied brains from the Japanese general population (the Hisayama study). In this study, we compared the expression patterns of AEBP1 in normal and AD brains, including in the hippocampus, using immunohistochemistry. The subjects were 24 AD cases and 52 non-AD cases. Brain specimens were immunostained with antibodies against AEBP1, tau protein, amyloid β protein, NF-κB, GFAP and Iba-1. In normal brains, AEBP1 immunoreactivity mainly localized to the perikarya of hippocampal pyramidal neurons, and its expression was elevated in the pyramidal neurons and some astrocytes in AD hippocampi. Although AEBP1 immunoreactivity was almost absent in neurons containing neurofibrillary tangles, AEBP1 was highly expressed in neurons with pretangles and in the tau-immunopositive, dystrophic neurites of senile plaques. Nuclear localization of NF-κB was also observed in certain AEBP1-positive neurons in AD cases. Comparison of AD and non-AD cases suggested a positive correlation between the expression level of AEBP1 and the degree of amyloid β pathology. These findings imply that AEBP1 protein has a role in the progression of AD pathology.

UR - http://www.scopus.com/inward/record.url?scp=85012124660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012124660&partnerID=8YFLogxK

U2 - 10.1111/bpa.12475

DO - 10.1111/bpa.12475

M3 - Article

C2 - 27997051

AN - SCOPUS:85012124660

VL - 28

SP - 58

EP - 71

JO - Brain Pathology

JF - Brain Pathology

SN - 1015-6305

IS - 1

ER -